{"protocolSection": {"identificationModule": {"nctId": "NCT00843479", "orgStudyIdInfo": {"id": "LIMED0006"}, "organization": {"fullName": "University of Campinas, Brazil", "class": "OTHER"}, "briefTitle": "The Aging Endocrine Pancreas: Characterization of the Entero-insular Axis Physiology in the Elderly", "officialTitle": "The Aging Endocrine Pancreas: Characterization of the Entero-insular Axis Physiology in the Elderly."}, "statusModule": {"statusVerifiedDate": "2013-03", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2009-06"}, "primaryCompletionDateStruct": {"date": "2010-09", "type": "ACTUAL"}, "completionDateStruct": {"date": "2010-09", "type": "ACTUAL"}, "studyFirstSubmitDate": "2009-02-12", "studyFirstSubmitQcDate": "2009-02-12", "studyFirstPostDateStruct": {"date": "2009-02-13", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2011-10-04", "resultsFirstSubmitQcDate": "2013-03-07", "resultsFirstPostDateStruct": {"date": "2013-04-22", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2013-03-07", "lastUpdatePostDateStruct": {"date": "2013-04-22", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Bruno Geloneze", "investigatorTitle": "Dr. Bruno Geloneze", "investigatorAffiliation": "University of Campinas, Brazil"}, "leadSponsor": {"name": "University of Campinas, Brazil", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Like most endocrine axes, the entero-insular axis is expected to go through an age-related physiological deterioration, what might contribute to special features of the elderly onset type 2 diabetes in comparison to middle-age.\n\nTwenty four NGT volunteers will be evaluated by a meal tolerance test (MTT) for incretin hormone measurements, and by the hyperglycemic clamp followed by an arginine test for assessing the beta-cell function and the acute insulin response. Others parameters as body composition and basic biochemistry will be also evaluated at Laboratory of Investigation on Metabolism and Diabetes - LIMED / State university of Campinas, Brazil.\n\nThe characterization of the glucagon-like peptide-1 (GLP-1) production, dipeptidyl peptidase IV (DPP-IV) activity and/or endocrine pancreas incretin-response at aging, might be an interesting evidence to reinforce an incretin-based therapeutic approach for elderly onset type 2 diabetes."}, "conditionsModule": {"conditions": ["Diabetes Mellitus, Type 2", "Insulin Resistance"], "keywords": ["diabetes mellitus, type 2", "Insulin resistance", "Aging", "Incretins", "DPP-IV protein, human", "Glucagon-Like Peptide 1", "Gastric Inhibitory Polypeptide", "insulin", "glucagon", "ghrelin"]}, "designModule": {"studyType": "OBSERVATIONAL", "designInfo": {"observationalModel": "CASE_CONTROL", "timePerspective": "CROSS_SECTIONAL"}, "bioSpec": {"retention": "SAMPLES_WITHOUT_DNA", "description": "Sera and plasma"}, "enrollmentInfo": {"count": 24, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Elderly NGT", "description": "Normoglycemic subjects 65-80 years old"}, {"label": "Middle-age NGT", "description": "Middle-age normoglycemic subjects 35 to 50 years old."}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Homeostasis Model Assessment Insulin Resistance (HOMA-IR) Index", "description": "Insulin sensitivity index calculated as HOMA-IR = (Glucose \\* Insulin) / 22.5, where glucose is mmol/L and insulin is mili-units (mU)/L. Higher values indicate lower insulin sensitivity.", "timeFrame": "within 1 month from screening visit"}, {"measure": "Glucose Infusion Rate", "description": "Whole-body insulin sensitivity, as estimated by the mean glucose infusion rate corrected for fat-free mass(FFM){mg\\*\\[kg(FFM)\\^-1\\]\\*min\\*10} at last 60 min of 180-min hyperglycemic clamp", "timeFrame": "within 1 month from screening visit"}, {"measure": "Adaptive Beta-cell Insulin Production. The Product of Meal Tolerance Test-derived Insulinogenic Index (IGI) for Clamp-derived Insulin Sensitivity Index (ISI) in Normoglycemic Subjects After 65 Years Old in Comparison With Middle-age Normoglycemic Subjects", "description": "Beta-cell function was determinated as the beta-cell secretion measured by meal tolerance test adjusted by insulin sensitivity assessed by the hyperglycemic clamp test:Insulinogenic Index/Insulin Sensitivity Index adjusted by free fat mass", "timeFrame": "within 1 month from screening visit"}, {"measure": "Distinctive Beta-cell Function From the Arginine Stimulation Test in Normoglycemic Subjects After Sixty-five Years Old in Comparison With Middle-age Normoglycemic Subjects.", "description": "Distinctive beta-cell function as measured by the disposition index - based on the acute insulin response from the arginine stimulation test versus glucose infusion rate adjusted by free fat mass from hyperglycemic clamp - in normoglycemic subjects after sixty-five years old in comparison with middle-age normoglycemic subjects.", "timeFrame": "within 1 month from screening visit"}], "secondaryOutcomes": [{"measure": "Serum Dipeptidyl Peptidase IV (DPP-IV) Concentration", "description": "measured in fasting serum sample by ELISA kit", "timeFrame": "within 1 month from screening visit"}, {"measure": "GLP-1 Area Under the Curve (AUC)", "description": "Area under the curve of glucagon-like peptide (GLP-1) concentrations (measured by ELISA kit) from time 0 to 180 min during a standard meal tolerance test, calculated by the trapezoidal rule.", "timeFrame": "1 month from screening visit"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Stable weight (\\< 5% variation) within the last three months\n* Age: 35 to 50 years old for middle-age group, and 65 to 80 years old for elderly group.\n* BMI: 20 to 29.9 kg/m2\n* Normal glucose tolerance (NGT) for groups Elderly and Middle-age\n\nExclusion Criteria:\n\n* Use of estrogen, progestogen or systemic corticosteroids.\n* Hepatic cirrhosis, renal failure or any clinical condition with impaired insulin sensitivity\n* Smoking\n* Obesity\n* Uncontrolled systemic or debilitating diseases", "healthyVolunteers": true, "sex": "ALL", "minimumAge": "35 Years", "maximumAge": "80 Years", "stdAges": ["ADULT", "OLDER_ADULT"], "studyPopulation": "Adult normoglycemic subjects", "samplingMethod": "NON_PROBABILITY_SAMPLE"}, "contactsLocationsModule": {"overallOfficials": [{"name": "Bruno Geloneze, MD, PhD", "affiliation": "LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP)", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP)", "city": "Campinas", "state": "SP", "country": "Brazil", "geoPoint": {"lat": -22.90556, "lon": -47.06083}}]}, "referencesModule": {"references": [{"pmid": "24854384", "type": "DERIVED", "citation": "Geloneze B, de Oliveira Mda S, Vasques AC, Novaes FS, Pareja JC, Tambascia MA. Impaired incretin secretion and pancreatic dysfunction with older age and diabetes. Metabolism. 2014 Jul;63(7):922-9. doi: 10.1016/j.metabol.2014.04.004. Epub 2014 Apr 12."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Cross-sectional study conducted with 24 non-obese patients with normal glucose tolerance. Two groups formed: middle-aged (n=12) and aged(n=12). They were healthy and had no significant illness. None were taking drugs that affect insulin sensitivity/secretion or incretin hormones.", "recruitmentDetails": "The recruitment process took place at the Laboratory of Investigation on Metabolism and Diabetes - LIMED, located at the Medical School of the State University of Campinas (UNICAMP).", "groups": [{"id": "FG000", "title": "Elderly Normal Glucose Tolerance (NGT)", "description": "Normoglycemic subjects 65-80 years old"}, {"id": "FG001", "title": "Middle-age Normal Glucose Tolerance (NGT)", "description": "Middle-age normoglycemic subjects 35 to 50 years old."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "12"}, {"groupId": "FG001", "numSubjects": "12"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "12"}, {"groupId": "FG001", "numSubjects": "12"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Elderly Normal Glucose Tolerance (NGT)", "description": "Normoglycemic subjects 65-80 years old"}, {"id": "BG001", "title": "Middle-age Normal Glucose Tolerance (NGT)", "description": "Middle-age normoglycemic subjects 35 to 50 years old."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "24"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0", "spread": "0"}, {"groupId": "BG001", "value": "0", "spread": "0"}, {"groupId": "BG002", "value": "0", "spread": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "0", "spread": "0"}, {"groupId": "BG001", "value": "12", "spread": "0"}, {"groupId": "BG002", "value": "12", "spread": "0"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "12", "spread": "0"}, {"groupId": "BG001", "value": "0", "spread": "0"}, {"groupId": "BG002", "value": "12", "spread": "0"}]}]}]}, {"title": "Age Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "64", "spread": "2"}, {"groupId": "BG001", "value": "44", "spread": "4"}, {"groupId": "BG002", "value": "54", "spread": "3"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "11"}, {"groupId": "BG002", "value": "20"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "4"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Brazil", "categories": [{"measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "24"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Homeostasis Model Assessment Insulin Resistance (HOMA-IR) Index", "description": "Insulin sensitivity index calculated as HOMA-IR = (Glucose \\* Insulin) / 22.5, where glucose is mmol/L and insulin is mili-units (mU)/L. Higher values indicate lower insulin sensitivity.", "populationDescription": "minimum number required to find a significant difference between groups considering the intra-subject variation", "reportingStatus": "POSTED", "anticipatedPostingDate": "2011-09", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "units on a scale", "timeFrame": "within 1 month from screening visit", "groups": [{"id": "OG000", "title": "Elderly Normal Glucose Tolerance (NGT)", "description": "Normoglycemic subjects 65-80 years old"}, {"id": "OG001", "title": "Middle-age Normal Glucose Tolerance (NGT)", "description": "Middle-age normoglycemic subjects 35 to 50 years old."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "12"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.91", "spread": "1.0"}, {"groupId": "OG001", "value": "0.84", "spread": "0.21"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.001", "statisticalMethod": "Wilcoxon (Mann-Whitney)", "paramType": "Mean Difference (Final Values)", "paramValue": "1.07"}]}, {"type": "PRIMARY", "title": "Glucose Infusion Rate", "description": "Whole-body insulin sensitivity, as estimated by the mean glucose infusion rate corrected for fat-free mass(FFM){mg\\*\\[kg(FFM)\\^-1\\]\\*min\\*10} at last 60 min of 180-min hyperglycemic clamp", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg*[kg(FFM)^-1]*min*10", "timeFrame": "within 1 month from screening visit", "groups": [{"id": "OG000", "title": "Elderly Normal Glucose Tolerance (NGT)", "description": "Normoglycemic subjects 65-80 years old"}, {"id": "OG001", "title": "Middle-age Normal Glucose Tolerance (NGT)", "description": "Middle-age normoglycemic subjects 35 to 50 years old."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "12"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.48", "spread": "0.16"}, {"groupId": "OG001", "value": "1.73", "spread": "0.13"}]}]}], "analyses": [{"groupIds": ["OG000"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.001", "statisticalMethod": "Wilcoxon (Mann-Whitney)", "paramType": "Mean Difference (Final Values)", "paramValue": "1.25", "ciPctValue": "95"}]}, {"type": "PRIMARY", "title": "Adaptive Beta-cell Insulin Production. The Product of Meal Tolerance Test-derived Insulinogenic Index (IGI) for Clamp-derived Insulin Sensitivity Index (ISI) in Normoglycemic Subjects After 65 Years Old in Comparison With Middle-age Normoglycemic Subjects", "description": "Beta-cell function was determinated as the beta-cell secretion measured by meal tolerance test adjusted by insulin sensitivity assessed by the hyperglycemic clamp test:Insulinogenic Index/Insulin Sensitivity Index adjusted by free fat mass", "reportingStatus": "POSTED", "anticipatedPostingDate": "2011-09", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "(\u03bcmol\u2219kg-1min-1)", "timeFrame": "within 1 month from screening visit", "groups": [{"id": "OG000", "title": "Elderly Normal Glucose Tolerance (NGT)", "description": "Normoglycemic subjects 65-80 years old"}, {"id": "OG001", "title": "Middle-age Normal Glucose Tolerance (NGT)", "description": "Middle-age normoglycemic subjects 35 to 50 years old."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "12"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1.7", "spread": "0.9"}, {"groupId": "OG001", "value": "3.4", "spread": "1.3"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.01", "statisticalMethod": "Wilcoxon (Mann-Whitney)", "ciPctValue": "95"}]}, {"type": "PRIMARY", "title": "Distinctive Beta-cell Function From the Arginine Stimulation Test in Normoglycemic Subjects After Sixty-five Years Old in Comparison With Middle-age Normoglycemic Subjects.", "description": "Distinctive beta-cell function as measured by the disposition index - based on the acute insulin response from the arginine stimulation test versus glucose infusion rate adjusted by free fat mass from hyperglycemic clamp - in normoglycemic subjects after sixty-five years old in comparison with middle-age normoglycemic subjects.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "(\u03bcmol\u2219kg-1.min-1)", "timeFrame": "within 1 month from screening visit", "groups": [{"id": "OG000", "title": "Elderly NGT", "description": "Normoglycemic subjects 65-80 years old"}, {"id": "OG001", "title": "Middle-age NGT", "description": "Middle-age normoglycemic subjects 35 to 50 years old"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "12"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "328.5", "spread": "303.4"}, {"groupId": "OG001", "value": "223.5", "spread": "174.9"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": ">0.05", "statisticalMethod": "Wilcoxon (Mann-Whitney)", "ciPctValue": "95"}]}, {"type": "SECONDARY", "title": "Serum Dipeptidyl Peptidase IV (DPP-IV) Concentration", "description": "measured in fasting serum sample by ELISA kit", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/ml", "timeFrame": "within 1 month from screening visit", "groups": [{"id": "OG000", "title": "Elderly Normal Glucose Tolerance (NGT)", "description": "Normoglycemic subjects 65-80 years old"}, {"id": "OG001", "title": "Middle-age Normal Glucose Tolerance (NGT)", "description": "Middle-age normoglycemic subjects 35 to 50 years old."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "12"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1466.6", "spread": "1088.8"}, {"groupId": "OG001", "value": "1458.2", "spread": "1006.9"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": ">0.05", "statisticalMethod": "Wilcoxon (Mann-Whitney)", "ciPctValue": "95"}]}, {"type": "SECONDARY", "title": "GLP-1 Area Under the Curve (AUC)", "description": "Area under the curve of glucagon-like peptide (GLP-1) concentrations (measured by ELISA kit) from time 0 to 180 min during a standard meal tolerance test, calculated by the trapezoidal rule.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/ml/min", "timeFrame": "1 month from screening visit", "groups": [{"id": "OG000", "title": "Elderly Normal Glucose Tolerance (NGT)", "description": "Normoglycemic subjects 65-80 years old"}, {"id": "OG001", "title": "Middle-age Normal Glucose Tolerance (NGT)", "description": "Middle-age normoglycemic subjects 35 to 50 years old."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "12"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1061.7", "spread": "354.4"}, {"groupId": "OG001", "value": "1027.1", "spread": "164.9"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": ">0.05", "statisticalMethod": "Wilcoxon (Mann-Whitney)", "ciPctValue": "95"}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "Elderly Normal Glucose Tolerance (NGT)", "description": "Normoglycemic subjects 65-80 years old", "seriousNumAffected": 0, "seriousNumAtRisk": 12, "otherNumAffected": 0, "otherNumAtRisk": 12}, {"id": "EG001", "title": "Middle-age Normal Glucose Tolerance (NGT)", "description": "Middle-age normoglycemic subjects 35 to 50 years old.", "seriousNumAffected": 0, "seriousNumAtRisk": 12, "otherNumAffected": 0, "otherNumAtRisk": 12}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr. Bruno Geloneze", "organization": "Laboratory of Investigation on Metabolism and Diabetes - LIMED / State University of Campinas - Brazil", "email": "bgeloneze@terra.com.br", "phone": "+55 19 35218589"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000003920", "term": "Diabetes Mellitus"}, {"id": "D000003924", "term": "Diabetes Mellitus, Type 2"}, {"id": "D000007333", "term": "Insulin Resistance"}], "ancestors": [{"id": "D000044882", "term": "Glucose Metabolism Disorders"}, {"id": "D000008659", "term": "Metabolic Diseases"}, {"id": "D000004700", "term": "Endocrine System Diseases"}, {"id": "D000006946", "term": "Hyperinsulinism"}], "browseLeaves": [{"id": "M7115", "name": "Diabetes Mellitus", "asFound": "Diabetes Mellitus", "relevance": "HIGH"}, {"id": "M7119", "name": "Diabetes Mellitus, Type 2", "asFound": "Diabetes Mellitus, Type 2", "relevance": "HIGH"}, {"id": "M10370", "name": "Insulin Resistance", "asFound": "Insulin Resistance", "relevance": "HIGH"}, {"id": "M11639", "name": "Metabolic Diseases", "relevance": "LOW"}, {"id": "M25403", "name": "Glucose Metabolism Disorders", "relevance": "LOW"}, {"id": "M7862", "name": "Endocrine System Diseases", "relevance": "LOW"}, {"id": "M9997", "name": "Hyperinsulinism", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC18", "name": "Nutritional and Metabolic Diseases"}, {"abbrev": "BC19", "name": "Gland and Hormone Related Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"browseLeaves": [{"id": "M10365", "name": "Insulin", "relevance": "LOW"}, {"id": "M9043", "name": "Glucagon", "relevance": "LOW"}, {"id": "M26997", "name": "Glucagon-Like Peptide 1", "relevance": "LOW"}, {"id": "M22554", "name": "Pancrelipase", "relevance": "LOW"}, {"id": "M173166", "name": "Insulin, Globin Zinc", "relevance": "LOW"}, {"id": "M27905", "name": "Incretins", "relevance": "LOW"}, {"id": "M13114", "name": "Pancreatin", "relevance": "LOW"}, {"id": "M8866", "name": "Gastric Inhibitory Polypeptide", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Hypo", "name": "Hypoglycemic Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "Gast", "name": "Gastrointestinal Agents"}]}}, "hasResults": true}